|Bid||57.51 x 0|
|Ask||57.59 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 25, 2016 - Nov 26, 2016|
|Forward Dividend & Yield||0.29 (0.50%)|
|Ex-Dividend Date||Jan 13, 2021|
|1y Target Est||10.00|
Shares in Brazilian medical lab company Diagnosticos da America SA soared more than 20% in Wednesday morning trading after the company concluded a share offering on Tuesday. Dasa, as the company is known, priced its shares at 58 reais, below the original price range, and they were trading mid-morning at 72 reais on Wednesday. Dasa was already a listed company, but as its liquidity was very low, the deal was considered a re-IPO.
Brazilian medical services firm Diagnósticos da América SA has announced a share offering of roughly 5 billion reais ($905.57 million), according to a securities filing published late on Tuesday. The offering will be mainly primary, but one of its shareholders will also sell a small stake in the company. Dasa's share offering comes as Brazil's private healthcare sector is experiencing a dealmaking boom, while the country struggles to deal with the coronavirus crisis.
Molson Coors Chief Communications & Corporate Affairs Officer Adam Collins joins Yahoo Finance Live to break down how Molson Coors and breweries are facing ramifications weeks after the Texas storm.